Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Finasteride may help some women with hair loss, but better options exist.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Fat cells are important for tissue repair and stem cell support in various body parts.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Curcumin can protect against mercury's harmful effects on brain and behavior.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Coenzyme Q10 may protect liver function but doesn't reduce hair loss from anthracycline antibiotics.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

Sowbhagya Chundi Legiyam helps postpartum women recover and prevent infections.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Women who had cancer treatment feel both positive and negative about their bodies.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Prenatal pesticide exposure may cause earlier breast development in girls.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.